John J. Toole
Geen lopende functies
Profiel
John J.
Toole has been Senior Vice President of Corporate Development since March 2008.
He joined Gilead in April 1990 as Director of Molecular and Cellular Biology and was promoted to Vice President-Biology in May 1996, Vice President-Clinical Research in 1998 and Senior Vice President-Clinical Research in August 2003.
Dr. Toole was Founding Scientist of Genetics Institute, Inc. He received a PhD in Molecular Biology from the State University of New York at Buffalo and an MD from the Stanford University School of Medicine.
Eerdere bekende functies van John J. Toole
Bedrijven | Functie | Einde |
---|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | - |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van John J. Toole
State University of New York at Buffalo | Doctorate Degree |
Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |